| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430) | Travera Inc | 2022-07-15 |
| Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS (NCT04189107) | Rigshospitalet, Denmark | 2020-08-18 |
| Cancer Genetic Testing in Ethnic Populations (NCT04475640) | Mayo Clinic | 2020-01-13 |
| Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP) (NCT03391973) | AHS Cancer Control Alberta | 2018-08-24 |
| Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150) | M.D. Anderson Cancer Center | 2016-12-29 |
| Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic (NCT02721732) | M.D. Anderson Cancer Center | 2016-08-15 |
| Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary (NCT02590055) | Samsung Medical Center | 2015-10-01 |
| Genomic Investigation of Unusual Responders (NCT03740503) | University Health Network, Toronto | 2013-11-01 |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT01366144) | National Cancer Institute (NCI) | 2011-06-20 |
| Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary (NCT02764216) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2010-01-01 |
| Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary (NCT00873119) | Valerio Therapeutics | 2009-02-01 |
| PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy (NCT00388024) | Wake Forest University Health Sciences | 2006-02-01 |
| Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors (NCT00112619) | Pediatric Brain Tumor Consortium | 2005-08-01 |
| Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin (NCT00119314) | University of Medicine and Dentistry of New Jersey | 2004-07-01 |
| Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary (NCT00066781) | Alliance for Clinical Trials in Oncology | 2004-02-01 |
| Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor (NCT00047125) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-07-01 |
| Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site (NCT00148135) | University of Michigan Rogel Cancer Center | 2001-05-01 |
| SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck (NCT00006361) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin (NCT00022178) | The Christie NHS Foundation Trust | 1998-12-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. (NCT00003943) | Fox Chase Cancer Center | 1998-09-01 |
| Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin (NCT00003558) | Academisch Ziekenhuis Maastricht | 1998-08-01 |
| Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer (NCT00002507) | Yale University | 1992-11-01 |